ASTX
ASTEX PHARMACEUTICALS, INC COM
ASTX
ASTX
Delisted
ASTX was delisted on the 10th of October, 2013.
123 hedge funds and large institutions have $487M invested in ASTEX PHARMACEUTICALS, INC COM in 2013 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 31 increasing their positions, 32 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
3% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 32
Holders
123
Holding in Top 10
–
Calls
$31.7M
Puts
$29.7M
Top Buyers
| 1 | +$30.8M | |
| 2 | +$20.7M | |
| 3 | +$19.4M | |
| 4 |
SAM
Sandell Asset Management
New York
|
+$17.9M |
| 5 |
Millennium Management
New York
|
+$16.1M |
Top Sellers
| 1 | -$28.7M | |
| 2 | -$15.3M | |
| 3 | -$13.6M | |
| 4 |
O
OrbiMed
New York
|
-$13.4M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$10.1M |
